Coramaze Technologies

Company Overview

Snapshot

Founded in January 2013, Coramaze Technologies operates with 11–50 employees. The company has raised $6.26M across two funding rounds from four investors. In September 2015, Coramaze Technologies secured funding for its Mitramaze Valve Repair System.

Business overview

Coramaze Technologies is a Health Tech & Life Sciences company focused on developing medical devices for cardiovascular health. The company's core product is Tripair, a percutaneous treatment designed for tricuspid valve disease. This implant aims to improve the quality of life and reduce morbidity for heart failure patients suffering from tricuspid regurgitation. Coramaze Technologies operates within the Medical Devices, Medical Treatment & Therapeutics sectors, serving the healthcare industry, particularly providers, across geomarkets including East Asia, Europe, Oceania, and North America.

Strategic signal

In September 2015, Coramaze Technologies raised funding for its Mitramaze Valve Repair System, highlighting the company's commitment to advancing its product pipeline in cardiac care. This investment signals continued investor confidence in Coramaze's innovative approach to treating heart valve diseases and its potential to address significant unmet medical needs in the cardiovascular market.

Company Intelligence Q&A

What is Coramaze Technologies' primary product?

Coramaze Technologies develops the Tripair, a percutaneous treatment for tricuspid valve disease, aimed at improving the quality of life for heart failure patients.

When was Coramaze Technologies founded?

Coramaze Technologies was founded in January 2013.

What was a key funding event for Coramaze Technologies?

In September 2015, Coramaze Technologies raised funding for its.

What was an earlier funding round for Coramaze Technologies?

In February 2014, Coramaze Technologies received funding to develop an innovative medical device for minimally invasive heart valve disease treatment, with.

What is the current stage of Coramaze Technologies' product development?

Coramaze Technologies' product, Tripair, is currently in the clinical trial stage.